The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: A retrospective long-term study

Journal of the American Academy of Dermatology

Volumn 66, Issue 5, 2012, Pages

  Saraceno, Rosita ^a   Specchio, Francesca ^a   Torres, Tiago ^b   Nisticò, Steven Paul ^a   Rizza, Stefano ^a   Chimenti, Sergio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR AUTOANTIBODY; AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; UNCLASSIFIED DRUG;

ADULT; ALLERGIC REACTION; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 84859816529     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.06.008     Document Type: Article

References (4)

1. Eriksson C, Engstrand S, Sundqvist KG, Rantapää-Dahlqvist S. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF-alpha. Ann Rheum Dis 2005;64:403-7. (Pubitemid 40283050)
2. Fusconi M, Vannini A, Dall'Aglio AC, Pappas G, Bianchi FB, Zauli D. Etanercept and infliximab induce the same serological autoimmune modifications in patients with rheumatoid arthritis. Rheumatol Int 2007;28:47-9. (Pubitemid 47497823)
3. Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P. Autoimmunity and anti-TNF-alpha agents. Ann N Y Acad Sci 2005;1051:559-69.
4. Pink AE, Fonia A, Allen MH, Smith CH, Barker JN. Antinuclear antibodies associated with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study. Br J Dermatol 2010;162:780-5.